IRDABISANT
UNII WH7ISP34KA

Substance Identification & Data

This profile provides standardized clinical and technical data for Irdabisant, uniquely identified by the FDA Unique Ingredient Identifier (UNII) WH7ISP34KA.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 1005402-19-6 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

WH7ISP34KA

CAS Registry Number

1005402-19-6

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

IRDABISANT

Official standardized name for this substance within the FDA UNII nomenclature system.

InChIKey

C18H23N3O2

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

XUKROCVZGZNGSI-CQSZACIVSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C170078

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

25070031

Unique identification number in the NCBI database of chemical substances.

INN ID

9470

Sequential identifier assigned via the WHO International Nonproprietary Name program.

USAN ID

XX-146

Identifier assigned by the United States Adopted Names Council.

Substance Type

chemical

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

N1([C@@H](CCC1)C)CCCOc2ccc(cc2)-c3ccc([nH]n3)=O

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Irdabisant. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.